Recce Pharmaceuticals awarded $191M R&D funding from Australian government, boosting global anti-infective program. Major step in combating antibiotic resistance.
Recce Pharmaceuticals has been granted a new patent in Canada for its anti-infective drugs, extending its market exclusivity until 2041. The patent covers a range of bacterial and viral pathogens, bolstering the company's commitment to innovation in combating antibiotic resistance and emerging viral threats.
Recce Pharmaceuticals has been granted a new patent in Canada for its anti-infective drugs, extending its market exclusivity until 2041. The patent covers a range of bacterial and viral pathogens, bolstering the company's commitment to innovation in combating antibiotic resistance and emerging viral threats.
Recce Pharmaceuticals awarded $191M R&D funding from Australian government, boosting global anti-infective program. Major step in combating antibiotic resistance.